Pharmacogenomic data sample collection and storage: ethical issues and policy approaches
This journal highlighted that CARTaGENE’s data would become more important over time in pharmocogenomic research to find out the association between genetic variations and drug-related effects. The ability of database creators to meet ethical issues will determine how pharmocogenomics can be integrated into mainstream clinical practice.
Population-based cohort development in Alberta, Canada: A feasibility study
This study reached out to 226252 people, where 11865 enrolled . 84% of those people were from Alberta. 97% of the group studied agreed to be linked with healthcare data and 91% agreed they would provide blood samples. This study showed that Alberta could have a very diverse cohort to be studied and examine health outcomes.
Predictors of colorectal cancer screening: a comparison of men and women.
The study found screening for colorectal cancer in average-risk adults was infrequent in this sample and lagged behind screening for other cancers. They suggested that educational programs might afford more success for people to get screened.
Strategies for consulting with the community: The cases of four large-scale genetic databases
This journal outlined how CARTaGENE is taking a partnership approach so that they could get more participation in their studies and better develop their databases.